AI in the Exam Room: 2025 Studies Show DermaSensor Helps Doctors Catch More Melanomas
New 2025 data shows an FDA-cleared AI device helps primary-care doctors miss fewer melanomas, but it doesn't replace your dermatologist.
Two studies reported in November 2025 found the FDA-cleared, AI-powered DermaSensor device raised primary-care physicians' melanoma detection from 70.2% to 79.1%, cutting missed melanomas from 29.8% to 20.9%, with device melanoma sensitivity around 95.5%.
Researchers behind the device frame it as a decision-support aid for non-specialists, designed to flag lesions that warrant referral rather than to deliver a final diagnosis.
Questions we get a lot
How much does DermaSensor improve melanoma detection?
In the November 2025 studies, primary-care physicians' melanoma detection rose from 70.2% to 79.1% when using the device. That cut missed melanomas from 29.8% to 20.9%. The device itself showed melanoma sensitivity around 95.5%.
Does an AI skin scanner replace seeing a dermatologist?
No. Devices like DermaSensor are designed as decision-support tools for primary-care settings, helping flag lesions that need further attention. They do not provide a definitive diagnosis. A dermatologist's evaluation and biopsy when needed remain the standard for confirming skin cancer.
r/Melanoma: 'My GP used some AI scanner on a mole instead of sending me to a derm. Should I still push for a specialist?'